Skip to main content

Table 3 ICU-specific antimicrobial consumption in DOTs, KAMC-R, 2012–2015

From: Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study

 

Medical/ surgical

Neuro-surgical

Burn

Cardio-thoracic

Step-down

Total

Number of DOTs

 Aminoglycosides

683

146

97

55

477

1458

 Carbapenems

6609

1302

960

725

3161

12,757

 Cephalosporins

1216

480

141

76

542

2455

 Fluoroquinolones

1677

399

209

255

1169

3709

 Piperacillin/Tazobactam

3473

1387

574

1018

1444

7896

 Vancomycin

3438

944

518

539

1570

7009

 Tigecycline

512

8

294

53

296

1163

 Colistin

3002

642

840

183

1693

6360

 Caspofungin

2322

183

167

146

924

3742

 Amphotericin B

218

13

20

0

140

391

 Total

23,150

5504

3820

3050

11,416

46,940

Rates per 1000 patient-days

 Aminoglycosides

35.7

20.0

14.4

7.7

34.4

26.9

 Carbapenems

345.9

178.6

142.0

102.0

228.1

235.7

 Cephalosporins

63.6

65.9

20.9

10.7

39.1

45.4

 Fluoroquinolones

87.8

54.7

30.9

35.9

84.3

68.5

 Piperacillin/Tazobactam

181.8

190.3

84.9

143.3

104.2

145.9

 Vancomycin

180.0

129.5

76.6

75.9

113.3

129.5

 Tigecycline

26.8

1.1

43.5

7.5

21.4

21.5

 Colistin

157.1

88.1

124.3

25.8

122.2

117.5

 Caspofungin

121.5

25.1

24.7

20.5

66.7

69.1

 Amphotericin B

11.4

1.8

3.0

0.0

10.1

7.2

 Total

1211.7

755.2

565.2

429.3

823.7

867.4